193 related articles for article (PubMed ID: 15883924)
1. Insomnia.
Holzinger E
IDrugs; 2005 May; 8(5):410-5. PubMed ID: 15883924
[TBL] [Abstract][Full Text] [Related]
2. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
Najib J
Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
[TBL] [Abstract][Full Text] [Related]
3. Eszopiclone (Lunesta) for treatment of transient and chronic insomnia.
Wessell AM; Weart CW
Am Fam Physician; 2005 Jun; 71(12):2359-60. PubMed ID: 15999875
[No Abstract] [Full Text] [Related]
4. Eszopiclone (Lunesta), a new hypnotic.
Med Lett Drugs Ther; 2005 Feb; 47(1203):17-9. PubMed ID: 15767972
[TBL] [Abstract][Full Text] [Related]
5. Eszopiclone for insomnia.
Melton ST; Wood JM; Kirkwood CK
Ann Pharmacother; 2005 Oct; 39(10):1659-66. PubMed ID: 16131537
[TBL] [Abstract][Full Text] [Related]
6. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
7. The role of eszopiclone in the treatment of insomnia.
Morin AK; Willett K
Adv Ther; 2009 May; 26(5):500-18. PubMed ID: 19513631
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic management of insomnia.
Walsh JK
J Clin Psychiatry; 2004; 65 Suppl 16():41-5. PubMed ID: 15575804
[TBL] [Abstract][Full Text] [Related]
9. Eszopiclone: esopiclone, estorra, S-zopiclone, zopiclone--Sepracor.
Drugs R D; 2005; 6(2):111-5. PubMed ID: 15777104
[TBL] [Abstract][Full Text] [Related]
10. Insomnia. Diagnosis and management.
Grunstein R
Aust Fam Physician; 2002 Nov; 31(11):995-1000. PubMed ID: 12471955
[TBL] [Abstract][Full Text] [Related]
11. Management of chronic insomnia in elderly persons.
Bain KT
Am J Geriatr Pharmacother; 2006 Jun; 4(2):168-92. PubMed ID: 16860264
[TBL] [Abstract][Full Text] [Related]
12. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
Soares CN; Joffe H; Rubens R; Caron J; Roth T; Cohen L
Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model.
Botteman MF; Ozminkowski RJ; Wang S; Pashos CL; Schaefer K; Foley DJ
CNS Drugs; 2007; 21(4):319-34. PubMed ID: 17381185
[TBL] [Abstract][Full Text] [Related]
14. [Management of insomnia].
Syvälahti E
Duodecim; 1989; 105(21):1728-33. PubMed ID: 2573508
[No Abstract] [Full Text] [Related]
15. [Sleeping poorly due to sedatives (rebound insomnia) and the role of zopiclone].
van Dam JG
Ned Tijdschr Geneeskd; 1992 Jun; 136(24):1175-6. PubMed ID: 1608486
[No Abstract] [Full Text] [Related]
16. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
17. Eszopiclone: an update on its use in insomnia.
Owen RT
Drugs Today (Barc); 2011 Apr; 47(4):263-75. PubMed ID: 21573250
[TBL] [Abstract][Full Text] [Related]
18. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
Boyle J; Trick L; Johnsen S; Roach J; Rubens R
Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
Roth T; Walsh JK; Krystal A; Wessel T; Roehrs TA
Sleep Med; 2005 Nov; 6(6):487-95. PubMed ID: 16230048
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and pharmacologic management options for insomnia.
Benca RM
Postgrad Med; 2004 Dec; 116(6 Suppl Insomnia):23-32. PubMed ID: 19667688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]